Featured Research

Seattle Children’s Early T1D Program supports kids and young adults at risk for type 1 diabetes and offers a therapy that can delay its onset.

Seattle Children’s scientist are working to better understand why T2D is becoming more prevalent in you people and what we can do about it.

Dr. Alpana Waghmare is working to protect cancer patients from infection-related complications through prediction, prevention and early intervention.

Seattle Children’s is strengthening pediatric emergency care through a national network, advancing training, telehealth and disaster preparedness for kids.

Researchers at Seattle Children’s use evidence-based interventions to encourage vaccine uptake in pediatric populations.

Seattle Children’s Emergency Department research helps improve care for acute injuries or illnesses.

Research study reviews effects of rapid genetic testing for non-ICU patients. Findings promise effective and timely treatment.

Seattle Children’s Research Institute and Washington State University Health Sciences aim to tackle pediatric issues with the strengths of both institutions.

Seattle Children’s researchers Seattle STRIDE study to learn how and why inflammatory bowel disease (IBD) begins in children, with goal of targeted therapies.

A screening platform using zebrafish reveals an antibiotic combination protects against hearing injury caused by medications.

Seattle Children’s Emergency Department Research group contributes emergency care research to national network.

Pediatric rheumatologist and nephrologist Dr. Shaun Jackson will co-lead kidney imaging studies with a multidisciplinary team studying pediatric lupus nephritis.

Research conducted with the Center for Clinical and Translational Research finds new data confirming COVID-19 vaccine safe for routine immunization for youngest children.

{publishdate} {teaser}